Azacytidine prevents experimental xenogeneic graft-versus-host disease without abrogating graft-versus-leukemia effects

  • Grégory Ehx, Gilles Fransolet, Laurence de Leval, Stéphanie D'Hondt, Sophie Lucas, Muriel Hannon, Loïc Delens, Sophie Dubois, Pierre Drion, Yves Beguin, Stéphanie Humblet-Baron, Frédéric Baron
  • OncoImmunology, April 2017, Taylor & Francis
  • DOI: 10.1080/2162402x.2017.1314425

The authors haven't yet claimed this publication.

Read Publication

http://dx.doi.org/10.1080/2162402x.2017.1314425